Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 20, 2018
Pharmacy Choice - Pharmaceutical News - Appili Therapeutics to Present at 2018 Atlantic Venture Forum Technology Showcase - July 20, 2018

Pharmacy News Article

 6/21/18 - Appili Therapeutics to Present at 2018 Atlantic Venture Forum Technology Showcase

HALIFAX, Nova Scotia(BUSINESS WIRE) Appili Therapeutics Inc. (the Company or Appili), a biopharmaceutical company focused on anti-infective drug development, announced today that it will present at the 2018 Atlantic Venture Forum Technology Showcase. The event takes place June 28-29, 2018 in Halifax, Canada.

Appili's Chief Executive Officer Kevin Sullivan will present a corporate overview and update on the Company's active pipeline and business development programs.

Presentation details are as follows:
Date: Thursday, June 28, 2018
Time: 2 p.m. Atlantic time
Session: Growth Stage Presenting Companies
Location: Halifax Marriott Harbourfront Hotel

Learn more about the Technology Showcase.

About Appili Therapeutics
Appili Therapeutics, Inc., was founded to advance the global fight against infectious disease by matching clearly-defined patient needs with drug development programs that provide solutions to existing challenges patients, doctors and society face in this challenging disease space. Balancing near-to-market product candidates with higher-risk but potentially transformative early-stage programs, Appili's growing pipeline includes assets being developed by Appili as well as an active licensing program. ATI-1501 employs Appili's proprietary, taste-masked, oral-suspension technology with metronidazole for the growing number of pediatric and elderly patients with difficulty swallowing. ATI-1503 is a drug discovery program aimed at generating negamycin analogue candidates, a novel class of antibiotics with broad-spectrum activity against Gram-negative bacteria. Via an in-licensing program, Appili acquired the rights to ATI-1701, a vaccine for tularemia, removing risk from a weaponized bioterrorism pathogen. Headquartered in Halifax, Nova Scotia, with offices in Mississauga, Ontario, Appili is pursuing worldwide opportunities in collaboration with science and industry commercial partners, governments and government agencies. For more information, visitwww.AppiliTherapeutics.com.

Media Relations Contact:

Sam Brown Inc.

Mike Beyer, 312-961-2502

mikebeyer@sambrown.com

or

Investor Relations Contact:

Appili Therapeutics

Kimberly Stephens, CFO

Info@AppiliTherapeutics.com

Source: Appili Therapeutics Inc.



Copyright Business Wire 2018

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Jul 23: Management of Major Depressive Disorders
Jul 24: Smoking Cessation: A Toolkit for Pharmacy Professionals
Jul 25: A Primer to Paleo
Jul 26: Shingles Immunization: What’s New?
Jul 27: Medical Marijuana: The Basic and Clinical Pharmacology, Not The Politics
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415